Roger Pomerantz
CIK 1614936 · Chief Executive Officer · last filed 2025-06-11
Roger Pomerantz is a Chief Executive Officer who has filed 67 SEC Form 4 insider transactions across 8 companies since 2014. The most recent filing, for INDP, was dated Jun 11, 2025. Across all open-market trades the lifetime net is −$19.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.22M
8
67
-$19.58M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INDP | Director | — | $3.58 | — | $0 | 6 | 2025-06-11 |
| Viracta Therapeutics, Inc. (VIRX) Delisted | Director | 126,478 | $0.01 | $1.2K | $0 | 19 | 2024-11-27 |
| CONTRAFECT Corp (CFRX) Delisted | Chief Executive Officer | 800 | $0.05 | $40 | $992 | 7 | 2022-02-17 |
| Intec Pharma Ltd. (NTEC) Delisted | Director | — | $9.63 | — | $0 | 2 | 2020-07-17 |
| MCRB | President and CEO | 213,976 | $5.70 | $1.22M | -$19.58M | 27 | 2019-06-14 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Director | 100 | $0.08 | $8 | $2.3K | 2 | 2018-07-23 |
| CONTRAFECT Corp (CFRX.W) Delisted | Director | — | — | — | $0 | 1 | 2016-05-11 |
| CONTRAFECT Corp (CFRX.Z) Delisted | Director | — | — | — | $0 | 3 | 2015-05-06 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-11 | INDP | Grant (A) | — | $0 | EDGAR |
| 2025-04-11 | INDP | Disp (D) | — | $0 | EDGAR |
| 2024-11-27 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,034 | $0 | EDGAR |
| 2024-09-12 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,034 | $0 | EDGAR |
| 2024-06-24 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | INDP | Grant (A) | — | $0 | EDGAR |
| 2024-05-29 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,035 | $0 | EDGAR |
| 2024-02-27 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,034 | $0 | EDGAR |
| 2023-11-28 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,034 | $0 | EDGAR |
| 2023-08-29 | Viracta Therapeutics, Inc. (VIRX) Delisted | Exer (M) | +9,034 | $0 | EDGAR |